Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01432093 · ClinicalTrials.gov registry record · NA
Intensive Glycemic Management and Outcomes Following Liver Transplantation
A NA study of Hospital Hyperglycemia and Post-transplant Hyperglycemia, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT01432093 is a NA study of Hospital Hyperglycemia and Post-transplant Hyperglycemia that has completed, run by Mayo Clinic. The registered enrollment target is 270 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01432093, a NA study of Hospital Hyperglycemia and Post-transplant Hyperglycemia, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
Most people develop high blood sugars following liver transplant that requires treatment with insulin in the hospital, even if they don't have diabetes, due to stress and use of steroid medications. High blood sugar levels can be treated with a hormone that the body makes called insulin. This study is being done to determine if maintaining normal blood sugar levels after transplant for as long as needed while in the hospital results in a lesser incidence of death, infections, transplanted liver rejection or failure or need for rehospitalization within 90 days after transplant.
Conditions Studied
Interventions
- OTHER Intensive glycemic management
- OTHER Conventional management
Study Locations (1)
Florida
- Mayo Clinic - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01432093
The ClinicalTrials.gov registry entry for NCT01432093 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hospital Hyperglycemia appearing as the primary indexed condition, and to 2 interventions - of which Intensive glycemic management is the first listed.
NCT01432093 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01432093 about?
NCT01432093 is a clinical study titled "Intensive Glycemic Management and Outcomes Following Liver Transplantation". Most people develop high blood sugars following liver transplant that requires treatment with insulin in the hospital, even if they don't have diabetes, due to stress and use of steroid medications. High blood sugar levels can be treated with a hormone that the body makes called insulin. This study ...
What is the current status of trial NCT01432093?
This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2011-10. Estimated completion is 2013-07.
What conditions does trial NCT01432093 study?
This clinical trial studies the following conditions: Hospital Hyperglycemia, Post-transplant Hyperglycemia.
What interventions are being tested in trial NCT01432093?
The interventions under investigation include: Intensive glycemic management (OTHER), Conventional management (OTHER).
Who is sponsoring clinical trial NCT01432093?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01432093 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.